# Denali Therapeutics Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/denali-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-19T14:43:40.33645+00:00 | | Last reviewed | 2026-10-19T14:43:40.33645+00:00 | ## Identity - Legal name: Denali Therapeutics Inc. - Display name: Denali Therapeutics Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-19T15:44:54.663566+00:00 | | Completeness | 0.409 | | Record Quality | 0.833 | | Directors | 10 | | Committees | 1 | | Governance events | 11 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - David Schenkein: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:6 - Jay Flatley: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:7 - Jennifer Cook: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:8 - Nancy A. Thornberry: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:9 - Peter Klein: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:10 - Ryan J. Watts, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:12 - Steve E. Krognes: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:13 - Tim Van Hauwermeiren: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:14 - Julian Baker: Chairperson of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:5 - Ryan J. Watts: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:11 ## Committees - Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Ryan J. Watts (member, unknown). committee_id=alpha:committee:denali-therapeutics-inc:chief-executive-officer-and-director ## Executive leadership - Alexander O. Schuth, M.D.: Chief Operating and Financial Officer, and Secretary. Status: current. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:16 - Peter Chin, M.D.: Chief Medical Officer, Head of Development. Status: current. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:19 - Ryan J. Watts, Ph.D.: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:21 - Alexander O. Schuth: Chief Operating and Financial Officer and Secretary. Status: unknown. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:15 - Carole Ho, M.D.: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:17 - Peter Chin: Chief Medical Officer, Head of Development. Status: unknown. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:18 - Ryan J. Watts: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:20 ## Governance events - EXECUTIVE_APPOINTED: Alexander O. Schuth, M.D. executive of Denali Therapeutics Inc., effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:5bmg3cu9f57e - EXECUTIVE_APPOINTED: Peter Chin, M.D. executive of Denali Therapeutics Inc., effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:1a3fonm8foway - CEO_CHANGED: Ryan J. Watts, Ph.D. executive of Denali Therapeutics Inc., effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:v2inra135l4bc - DIRECTOR_APPOINTED: Tim Van Hauwermeiren seat on Denali Therapeutics Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:aqfhnt3xmqtb - DIRECTOR_APPOINTED: Steve E. Krognes seat on Denali Therapeutics Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:uimpi11xpl2q7 - DIRECTOR_APPOINTED: Nancy A. Thornberry seat on Denali Therapeutics Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:myg15916du8tz - DIRECTOR_APPOINTED: Jennifer Cook seat on Denali Therapeutics Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:11w5kxoji522g - DIRECTOR_APPOINTED: Peter Klein seat on Denali Therapeutics Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:1vtu4wr1yshe4l - DIRECTOR_APPOINTED: David Schenkein seat on Denali Therapeutics Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:25bh5vcumswj - DIRECTOR_APPOINTED: Jay Flatley seat on Denali Therapeutics Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:7ny7wsiwvtfi - DIRECTOR_APPOINTED: Ryan J. Watts, Ph.D. seat on Denali Therapeutics Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:1nx911k2kkp6y ## Scoped resources - `alpha://company/denali-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record - `alpha://company/denali-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=identity - `alpha://company/denali-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/denali-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=board - `alpha://company/denali-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=committees - `alpha://company/denali-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=leadership - `alpha://company/denali-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=ownership - `alpha://company/denali-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=financials - `alpha://company/denali-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/denali-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=compensation - `alpha://company/denali-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=governance - `alpha://company/denali-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/denali-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=audit - `alpha://company/denali-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=legal - `alpha://company/denali-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=risk - `alpha://company/denali-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=cyber - `alpha://company/denali-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/denali-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=agents - `alpha://company/denali-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/denali-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=events - `alpha://company/denali-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=relationships - `alpha://company/denali-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=assessments - `alpha://company/denali-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Julian Baker: Chairperson of the Board. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:56c430fbea28df31119f9f00d8f1cec370ae58bdc4d1c7eaa44f23cf45a2b6b0. - David Schenkein: Director. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:6. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e2f3e63ed66ad936c19384ccbd5aecb000077938d7e2532566a2734df6fbd553. - Jay Flatley: Director. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:7. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e2f3e63ed66ad936c19384ccbd5aecb000077938d7e2532566a2734df6fbd553. - Jennifer Cook: Director. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:8. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e2f3e63ed66ad936c19384ccbd5aecb000077938d7e2532566a2734df6fbd553. - Nancy A. Thornberry: Director. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e2f3e63ed66ad936c19384ccbd5aecb000077938d7e2532566a2734df6fbd553. - Peter Klein: Director. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:10. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e2f3e63ed66ad936c19384ccbd5aecb000077938d7e2532566a2734df6fbd553. - Ryan J. Watts: President, Chief Executive Officer and Director. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:56c430fbea28df31119f9f00d8f1cec370ae58bdc4d1c7eaa44f23cf45a2b6b0. - Ryan J. Watts, Ph.D.: Director. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:12. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e2f3e63ed66ad936c19384ccbd5aecb000077938d7e2532566a2734df6fbd553. - Steve E. Krognes: Director. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:13. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e2f3e63ed66ad936c19384ccbd5aecb000077938d7e2532566a2734df6fbd553. - Tim Van Hauwermeiren: Director. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:14. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e2f3e63ed66ad936c19384ccbd5aecb000077938d7e2532566a2734df6fbd553. - Alexander O. Schuth: Chief Operating and Financial Officer and Secretary. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:56c430fbea28df31119f9f00d8f1cec370ae58bdc4d1c7eaa44f23cf45a2b6b0. - Alexander O. Schuth, M.D.: Chief Operating and Financial Officer, and Secretary. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:16. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4a60ea139cbf78d85e0c150b3a5d03ba1e4bb08f3532d4097ee5116d881b9268. - Carole Ho, M.D.: Chief Medical Officer. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a5176776d5079ef1e490eb770f4396fa8c880671460e33f53797143b922c1321. - Peter Chin: Chief Medical Officer, Head of Development. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:56c430fbea28df31119f9f00d8f1cec370ae58bdc4d1c7eaa44f23cf45a2b6b0. - Peter Chin, M.D.: Chief Medical Officer, Head of Development. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:19. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18f6bc502da772ad8db0043041b5d55cee98e3fef71fa9084f11ac52cc7eb60. - Ryan J. Watts: President and Chief Executive Officer. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:56c430fbea28df31119f9f00d8f1cec370ae58bdc4d1c7eaa44f23cf45a2b6b0. - Ryan J. Watts, Ph.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:leadership_role:21. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:10af92a6c6674f4ed3947f37f503e1285141e5b31b87230ab857590491b3d333. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Denali Therapeutics Inc.. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b66d914f9c0a0b7f88da7535fd6a1ce6a0e7cc89c7dc6c22efe997de1cd8054. ## Entity Status - Public listing published. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b66d914f9c0a0b7f88da7535fd6a1ce6a0e7cc89c7dc6c22efe997de1cd8054. ## Published Fact - US. Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b66d914f9c0a0b7f88da7535fd6a1ce6a0e7cc89c7dc6c22efe997de1cd8054. ## Security Listing - DNLI (NASDAQ). Claim: alpha:claim:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2b66d914f9c0a0b7f88da7535fd6a1ce6a0e7cc89c7dc6c22efe997de1cd8054. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:2b66d914f9c0a0b7f88da7535fd6a1ce6a0e7cc89c7dc6c22efe997de1cd8054: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/denali-therapeutics-inc). - alpha:projection-evidence:document:56c430fbea28df31119f9f00d8f1cec370ae58bdc4d1c7eaa44f23cf45a2b6b0: [SEC DEF 14A 0001714899-26-000054](https://www.sec.gov/Archives/edgar/data/1714899/000171489926000054/dnli-20260421.htm). - alpha:projection-evidence:document:e2f3e63ed66ad936c19384ccbd5aecb000077938d7e2532566a2734df6fbd553: [DEF 14A dnli-20260421.htm](https://www.sec.gov/Archives/edgar/data/1714899/000171489926000054/dnli-20260421.htm). - alpha:projection-evidence:document:4a60ea139cbf78d85e0c150b3a5d03ba1e4bb08f3532d4097ee5116d881b9268: [DNLI DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1714899/000171489926000054/dnli-20260421.htm). - alpha:projection-evidence:document:a5176776d5079ef1e490eb770f4396fa8c880671460e33f53797143b922c1321: DNLI executive roster source. - alpha:projection-evidence:document:a18f6bc502da772ad8db0043041b5d55cee98e3fef71fa9084f11ac52cc7eb60: [DNLI DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1714899/000171489926000054/dnli-20260421.htm). - alpha:projection-evidence:document:10af92a6c6674f4ed3947f37f503e1285141e5b31b87230ab857590491b3d333: [DNLI DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1714899/000171489926000054/dnli-20260421.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/denali-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/denali-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/denali-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/denali-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-19T15:44:54.352643+00:00; recorded 2026-10-19T15:44:54.352643+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.